Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing
articles matching relapse — open any to read the full text,
or download the PDF or XML.
Jun 2026 DOI 10.14302/issn.2690-4721.ijcm-26-6039
Nidhi RaoCorresponding author
Background Mucormycosis is a rapidly progressive invasive fungal infection associated with high mortality in patients with hematological malignancies such as Acute Lymphoblastic Leukemia(ALL). Early diagnosis is challenging because clinical and radiological findings are often nonspecific, and tissue…
Dec 2017 DOI 10.14302/issn.2766-8630.jrnm-17-1770
Emad Y. MoawadCorresponding author
The aims of this study are to investigate the variation in the mechanical behaviour of the primary cancer from cancer relapse, and measuring the therapeutic resistance acquired by cancer relapse. A431-cultured cells were irradiated for 7 months until 85 Gy. Then, a selected single cell was left to g…
Dec 2025 DOI 10.14302/issn.2574-612X.ijpr-25-5849
Gülsüm YılmazCorresponding author
Bipolar disorder is a chronic condition marked by episodes of mania and depression, significant functional impairment, and challenges with treatment adherence. Current guidelines highlight the importance of both medication and psychosocial approaches in treatment. This review explores the primary ps…
Jul 2023 DOI 10.14302/issn.2470-5020.jnrt-23-4576
N. HECHAMCorresponding author
Background The evolution of multiple sclerosis (MS) is highly variable. Predicting this evolution at the beginning of the disease will help in the therapeutic management. The objective of this study was to describe the clinical characteristics and to identify early predictors of long-term disability…
Mar 2022 DOI 10.14302/issn.2692-1537.ijcv-22-4117
Jianqing WuCorresponding author
Several mRNA vaccines are used on the population in the U.S. I started predicting the dangers of mRNA vaccines before March 2021 and update my findings periodically. My prior model study enabled me to identify many flaws in clinical trials, side-effect evaluation methods and mechanism studies, and I…
Jan 2022
PrachiCorresponding author
Senior Resident, Department of Pathology, Dharamshila Narayana Super speciality Hospital, New Delhi
This case report describes plasma cell pleocytosis occurring after bone marrow transplantation for multiple myeloma. The authors outline clinical presentation, cerebrospinal fluid findings, and differential diagnosis, emphasizing the need to consider hematologic relapse or CNS involvement in post‑tr…
Nov 2019 DOI 10.14302/issn.2689-5773.jcdp-19-3061
Anubha BajajCorresponding author
Novel cancer therapeutics are superior and prevalent in the current scenario although a subset may not be satisfactorily alleviated or undergo disease relapse with the adoption of conventional chemotherapeutic agents. Cancer cells can comfortably elude immune destruction as interaction of cancer…
May 2019 DOI 10.14302/issn.2574-4526.jddd-19-2770
Andre-Jean RemyCorresponding author
Introduction In France 33% of patients didn’t take care of hepatitis C because there were no diagnosed. Drug injection was main contamination route of hepatitis C virus (HCV) in France. French guidelines were to treat all inmates and drug users, even fibrosis level. Access of HCV screening, care and…
May 2019 DOI 10.14302/issn.2328-0182.japst-19-2738
Aurore BARONCorresponding author
Rationale Prisons are major reservoirs of hepatitis C virus (HCV) in which a therapeutic approach has been particularly difficult so far. Prevalence of viral hepatitis C (HCV) is higher in prison environment in France than in the general population and is estimated to be 4,8%. The impact in prison e…
Jan 2018 DOI 10.14302/issn.2470-5020.jnrt-17-1926
Simon NagelCorresponding author
Since the first description in 2013, 39 cases of anti-DPPX-encephalitis have been described. Main features of this autoimmune encephalitis characterized by antibodies against the potassium-channel-associated regulatory protein DPPX are gastrointestinal symptoms, cognitive dysfunction and signs of CN…
Feb 2016 DOI 10.14302/issn.2372-6601.jhor-15-822
I.V. ChernikovCorresponding author
Institute of Chemical Biology and Fundamental Medicine SB RAS.
Small interfering RNA (siRNA) based drugs for overcoming multiple drug resistance of hematological malignancies could solve the problem of poor response to the chemotherapy and hight relapse rate. The main factor that significantly limits biomedical application of siRNA is inefficient delivery to ta…
Jun 2015 DOI 10.14302/issn.2576-182X.jbsc-14-576
Tejpal GuptaCorresponding author
Multi-modality therapy has led to significant improvement in outcomes for childhood medulloblastoma; however, long-term survivors have become more susceptible to late effects of therapy including induction of second malignant neoplasms and even remain at an increased risk of late relapses including…
Jan 2015 DOI 10.14302/issn.2372-6601.jhor-14-377
W Zaidah ACorresponding author
Background Abnormalities of plasma von Willebrand Factor (vWF) system has been described in solid tumors but more information is required to understand the pathophysiological process in haematological malignancies. Objectives This study was carried out to investigate the changes in vWF-related param…
Feb 2014 DOI 10.14302/issn.2372-6601.jhor-13-346
Chloe E. ClaphamCorresponding author
Targeting cell metabolism is a therapeutic approach which has been used for the treatment of cancers with high levels of proliferation. Inhibition of metabolic processes in cancer cells has shown synergy with current therapeutic options to reduce refractory disease and relapse. In contrast, chronic…